In 2019, the IFF initiated a total 93 doping controls and there were no anti-doping rule violations in the IFF initiated tests.
Out of these 93 IFF tests, 54 tests were conducted in the IFF Events (in-competition tests) and 39 were IFF out-of-competition tests including five samples analysed for ESAs (urine) and five samples analysed for GHRFs (urine).
Samples analysed for Erythropoiesis Stimulating Agents (ESAs, e.g. EPO) and Growth Hormone (GH)/Growth Hormone Releasing Factors (GHRFs) are on a 5 % level in floorball. This meets the requirements of the WADA Technical Document for Sport Specific Analysis (TDSSA). The objective of the TDSSA is to protect clean athletes by establishing Minimum Level Analysis for those prohibited substances that are at risk of abuse in particular sports.
The IFF Member Associations and/or National Anti-Doping Agencies have reported two Anti-Doping Rule Violations (ADRVs). The Swiss Olympic Disciplinary Chamber for Doping Cases announced the ADRV and sanction for cocaine (ADRV in 2018, sanction announced in 2019), read more here. The Disciplinary Anti-Doping Commission of Latvia announced the ADRV and sanction for meldonium, read more here.
The IFF doping control statistics are found here.